🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 for type 1 diabetes as adjunct — need advice Page 6

GLP-1 for type 1 diabetes as adjunct — need advice

SarahChen_PharmD Fri, Jan 31, 2025 at 10:02 PM 40 replies 1,803 viewsPage 6 of 8
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Feb 1, 2025 at 6:32 AM#26

Congrats SarahChen_PharmD!! Keep going — you're doing incredible. 🎉

Last edited: Feb 1, 2025 at 9:32 AM
13 18Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 10 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Feb 1, 2025 at 6:49 AM#27

Slightly tangential to GLP-1 for type 1 diabetes but Admin reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Feb 1, 2025 at 10:49 AM
4 24dave_SLC, FDA_TrackerJim, ricardo_MIA and 1 other
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Feb 1, 2025 at 7:06 AM#28

100%. My provider said the same thing about GLP-1 for type 1.

19 9DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 16 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Feb 1, 2025 at 7:23 AM#29

Reading this thread on GLP-1 for type 1 diabetes hits close to home. Dad of 2 checking in — I started at 269 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 44 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about GLP-1 for type 1 — take the leap. It was the best health decision I have ever made. ❤️

47 2roxy_nash, tony_orlando, Dr.NephBHM_UK and 44 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Feb 1, 2025 at 7:40 AM#30

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1 for type 1 diabetes as adjunct .

Building on what MikeFit_NJ said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Feb 1, 2025 at 10:40 AM
42 0mike_mod, SarahChen_PharmD, sarah.morrison and 39 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register